Company:  JOHNSON & JOHNSON (JNJ)
Form Type:  10-K
Filing Date:  2/22/2013 
CIK:  0000200406 
Address:  ONE JOHNSON & JOHNSON PLZ 
City, State, Zip:  NEW BRUNSWICK, New Jersey 08933 
Telephone:  732-524-2455 
Fiscal Year:  12/12 
Last Trade
Last Trade: 
$107.87  
Change: 
0.386 (0.36%)  
Trade Time: 
02:59 PM EST  
Market Cap: 
$301.93B
Description of Business
Johnson & Johnson and its subsidiaries (the "Company") have approximately 128,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 275 operating companies conducting business in virtually all countries of the world. The Company�s primary focus has been on products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887. The Company�s structure is based on the principle of decentralized management. The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Consumer, Pharmaceutical and Medical Devices and Diagnostics business segments.
Register for EDGAR Pro and access this filing in:     
  FORM 10-K
    PART I
      Item 1. BUSINESS
      Item 1A.RISK FACTORS
      Item 1B. UNRESOLVED STAFF COMMENTS
      Item 2. PROPERTIES
      Item 3. LEGAL PROCEEDINGS
        NAME AND TITLE
    PART II
      Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      Item 6. SELECTED FINANCIAL DATA
      Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      Item 9A. CONTROLS AND PROCEDURES
      Item 9B. OTHER INFORMATION
    PART III
      Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
      Item 11. EXECUTIVE COMPENSATION
      Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS ...
      Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, ...
      Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
    PART IV
      Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
    VALUATION AND QUALIFYING ACCOUNTS
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ON
    EXHIBIT INDEX
  EXHIBIT 10
  EXHIBIT 12
    RATIO COMPUTATION
  EXHIBIT 13
    BALANCE SHEET
    INCOME STATEMENT
    CASH FLOW
    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
      INCOME STATEMENT
    Report of Independent Registered Public Accounting Firm
      INCOME STATEMENT
  EXHIBIT 21
    SUBSIDIARIES
  EXHIBIT 23
    CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
  EXHIBIT 31.A
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 31.B
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 32.A
    CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  EXHIBIT 32.B
    CERTIFICATION OF CHIEF FINANCIAL OFFICER
  EXHIBIT 99
BROKERAGE PARTNERS